image
Enveric Biosciences, Inc. ENVB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.365
-8.06 %
$ 3.26 M
Market Cap
-0.1
P/E
BALANCE SHEET
4.3 M ASSETS
-78.01%
Growth Rates
1Year -78.01%
3Years 1.62%
5Years -32.03%
7Years -27.16%
10Years 98.76%
2.34 M LIABILITIES
-41.35%
Growth Rates
1Year -41.35%
3Years 50.96%
5Years -34.12%
7Years -29.78%
10Years 57.66%
1.96 M EQUITY
-86.67%
Growth Rates
1Year -86.67%
3Years -16.95%
5Years -28.89%
7Years -22.51%
10Years 58.29%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Enveric Biosciences, Inc.
image
Current Assets 3.58 M
Cash & Short-Term Investments 2.29 M
Receivables 225 K
Other Current Assets 1.07 M
Non-Current Assets 718 K
Long-Term Investments 0
PP&E 507 K
Other Non-Current Assets 211 K
Current Liabilities 2.34 M
Accounts Payable 1.22 M
Short-Term Debt 0
Other Current Liabilities 1.12 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994
ASSETS
Cash & Cash Equivalents 2.3 17.7 17.4 1.6 0.4 1.4 4.9 1.4 1.9 5.08 K 249 1.38 K 18.2 K 1.13 K 1.79 K 66.8 K 0.6 0.2 0.6 0.9 0.6 0.9 0.9 1.5 1.0 0.3 0.6 1.6 3.1 1.5
Short Term Investments 0 0 0 0 0 0 0 82.9 K 82.9 K 0 0 0 0 0 0 0 1.0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.2 0 0 0 6.4 7.9 8.8 8.1 4.9 0 0 0 0 0 0 0 0 74.8 K 0.2 0.3 0.3 0.5 0.4 0.5 0.7 0.1 0.9 0.8 0.4 100 K
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 K 0 13 K 7.99 K 93.2 K 0.3 0.3 0.2
Other Current Assets 1.1 1.3 0.8 1.4 0.8 0.8 0.9 0.5 0.3 0 4.22 K 4.22 K 4.22 K 0 0 2.84 K 46 K 50.1 K 68.2 K 0.1 35.4 K 82.9 K 0.1 26.5 K 45.3 K 65.7 K 0.3 0.3 100 K 100 K
Total Current Assets 3.6 18.4 17.7 2.3 7.6 10.1 14.6 10.1 7.2 5.08 K 4.47 K 5.6 K 22.4 K 1.13 K 1.79 K 69.7 K 1.6 0.3 0.7 1.3 1.0 1.4 1.4 2.0 1.7 0.5 1.9 3.0 3.9 1.9
PP&E 0.5 0.7 0.5 0 83.1 K 58.9 K 95 K 0.1 73.1 K 0 0 0 0 0 0 0 0 3.48 K 18.4 K 29.5 K 42 K 70.8 K 50.6 K 0.1 0.1 0.2 0.6 0.6 0.3 0.2
Intangible Assets 0.2 0.4 6.9 1.8 3.6 5.8 9.5 8.8 3.1 0 0 0 0 0 0 0 0 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0 0 0 0 0.2 0
Goodwill 0 0 1.6 0 13.7 13.7 21.9 17.1 3.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 (6.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 6.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.47 K 1.51 K 45.2 K 32.2 K 0 0 0.1 0 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 4.3 19.6 26.7 4.1 25.0 29.6 52.2 39.5 13.8 5.08 K 4.47 K 5.6 K 22.4 K 1.13 K 1.79 K 69.7 K 1.6 0.5 0.9 1.5 1.2 1.7 1.8 2.5 2.1 0.9 3.2 4.1 4.4 2.3
LIABILITIES
Accounts Payable 1.2 0.5 0.7 0.7 4.7 4.4 5.3 5.1 2.6 0 0 0 0 2.64 K 11.9 K 5.21 K 900 32.1 K 14.2 K 71.9 K 21.5 K 39 K 14.9 K 51.8 K 0.2 0.3 0.7 0.4 0.2 0.3
Short Term Debt 0 0.1 0.2 0 4.9 5.2 4.8 3.5 1.2 0 2 K 8 K 0 0 0 0 9.68 K 9.67 K 10.4 K 66.3 K 37.5 K 0.1 0.1 33.7 K 0.4 0.9 0.5 0.1 0 0
Other Current Liabilities 1.1 3.4 1.2 0 4.2 4.9 19.8 4.1 4.7 8.96 K 22.7 K 17.7 K 17.9 K 48 K 0 16 K 37.3 K 45.3 K 0.2 0.1 0.1 0.2 0.2 0.7 0.8 1.2 0.5 0.3 0.5 0.7
Total Current Liabilities 2.3 4.0 2.1 0.7 14.4 14.7 30.4 12.7 8.6 8.96 K 24.7 K 25.7 K 17.9 K 50.6 K 11.9 K 21.2 K 47.9 K 87.1 K 0.2 0.7 0.2 0.3 0.3 0.8 1.3 2.4 1.6 0.9 0.7 1.0
Long Term Debt 0 0 68.9 K 0 0 0 2.4 1.5 5.0 0 0 0 0 0 0 0 0 0 0 0 70.7 K 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0.7 0 0 4.2 0 13.6 0 0 0 0 0 0 0 0 0 0 0 1.18 K 1.03 K 1.03 K 0 0 0 0 33.4 K 0 0 0.3
Total Liabilities 2.3 4.0 4.4 0.7 14.4 18.9 32.7 27.8 13.6 8.96 K 24.7 K 25.7 K 17.9 K 50.6 K 11.9 K 21.2 K 47.9 K 87.1 K 0.2 0.7 0.2 0.3 0.3 0.8 1.3 2.4 1.6 0.9 0.7 0.9
EQUITY
Common Stock 27.4 K 20.8 K 0.3 0.1 25.2 K 0.4 0.2 0.1 0.1 0.2 0.1 0.1 0.1 65 K 0.7 0.7 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.3 0.2 0.2 0 0
Retained Earnings (96.5) (79.2) (60.7) (11.8) (40.5) (34.5) (15.0) (3.8) (1.1) (47.4) (47.4) (47.4) (47.4) (47.3) (47.3) (45.9) (45.7) (46.5) (46.2) (46.1) (45.9) (45.4) (45.5) (45.2) (45.6) (46.0) (40.2) (35.5) (10.1) (6.8)
Other Accumulative Comprehensive Income/Loss (0.6) (0.5) 30.8 K (0.2) 60 K 87 K 36.9 K 7.43 K 0 0 0 0 0 65 K 0 (1.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Equity 2.0 15.6 22.3 3.4 10.6 10.8 19.4 11.7 0.3 3.87 K 20.2 K 20.1 K 4.56 K 49.5 K 10.1 K 48.5 K 1.6 0.4 0.7 0.8 1.0 1.4 1.4 1.7 0.8 (1.6) 1.5 3.3 3.7 1.4
Total Liabilities and Equity 4.3 19.6 26.7 4.1 25.0 29.6 52.2 39.5 13.8 5.08 K 4.47 K 5.6 K 22.4 K 1.13 K 1.79 K 69.7 K 1.6 0.5 0.9 1.5 1.2 1.7 1.8 2.5 2.1 0.9 3.2 4.1 4.4 2.3
SHARES OUTSTANDING
Common Shares Outstanding 2.2 1.4 0.5 0.1 26.4 K 4.76 K 3 K 2.61 K 2.37 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K 1.32 K